Home LiteratureArticle Details
PMID: 12966420 Published · ppublish English Journal Article

Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer.

British journal of cancer ·Vol. 89 ·No. 6 ·2003-09-15 ·Pages 1028-30

Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ

Abstract

A score based on the combination of the systemic inflammatory response and albumin hazards ratio (HR) 1.70, 95% CI 1.23 - 2.35, P=0.001) was comparable in prognostic value to that based on stage and performance status (HR 1.48, 95% CI 1.12 - 1.95, P=0.006) in patients with inoperable non-small-cell lung cancer. The former is simple to measure and well standardised.

MeSH Terms
Adenocarcinoma/blood,diagnosis Albumins/analysis Biomarkers, Tumor/analysis C-Reactive Protein/analysis Carcinoma, Non-Small-Cell Lung/blood,diagnosis Carcinoma, Squamous Cell/blood,diagnosis Female Humans Hypoalbuminemia/complications Inflammation Karnofsky Performance Status Lung Neoplasms/blood,diagnosis Male Middle Aged Neoplasm Staging Prognosis Prospective Studies Retrospective Studies
Chemicals
Albumins Biomarkers, Tumor C-Reactive Protein
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Forrest L M
University Department of Surgery, Royal Infirmary, Glasgow G31 2ER, UK.
McMillan D C
McArdle C S
Angerson W J
Dunlop D J
References (16)
16 references, click to expand
  1. Prognostic factors in advanced gastrointestinal cancer patients with weight loss.
    Nutr Cancer. 2000;37(1):36-40 PMID: 10965517
  2. Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones.
    Clin Sci (Lond). 1999 Aug;97(2):215-23 PMID: 10409477
  3. Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer.
    Br J Cancer. 2001 Nov 30;85(11):1634-9 PMID: 11742480
  4. The role of C-reactive protein as a prognostic indicator in advanced cancer.
    Curr Oncol Rep. 2002 May;4(3):250-5 PMID: 11937016
  5. The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer.
    Br J Cancer. 2002 Jul 29;87(3):264-7 PMID: 12177792
  6. A prospective study of the impact of weight loss and the systemic inflammatory response on quality of life in patients with inoperable non-small cell lung cancer.
    Lung Cancer. 2003 Jun;40(3):295-9 PMID: 12781428
  7. A new international staging system for lung cancer.
    Chest. 1986 Apr;89(4 Suppl):225S-233S PMID: 3514171
  8. Nitrite/nitrate and cytokine levels in bronchoalveolar lavage fluid of lung cancer patients.
    Cancer. 1994 Sep 1;74(5):1546-51 PMID: 8062187
  9. Serum levels of interleukin 6 in patients with lung cancer.
    Br J Cancer. 1995 May;71(5):1095-8 PMID: 7734307
  10. Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients.
    J Clin Oncol. 1995 Oct;13(10):2600-5 PMID: 7595713
  11. The relationship between weight loss and interleukin 6 in non-small-cell lung cancer.
    Br J Cancer. 1996 Jun;73(12):1560-2 PMID: 8664130
  12. Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working Party.
    Eur J Cancer. 1997 Dec;33(14):2326-32 PMID: 9616276
  13. Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients.
    Nutr Cancer. 1998;31(2):101-5 PMID: 9770720
  14. Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma?
    Cancer. 1999 Jan 15;85(2):333-40 PMID: 10023700
  15. Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer.
    Cytokine. 1999 Jan;11(1):80-6 PMID: 10080883
  16. Best supportive care in non-small cell lung cancer: is there a role for radiotherapy and chemotherapy?
    Lung Cancer. 2001 Jun;32(3):213-26 PMID: 11390003
Article Info
Journal
British journal of cancer
Abbr.
Br J Cancer
ISSN
0007-0920
Published
2003-09-15
Pages
1028-30
Language
English
Region
England
NLM ID
0370635
PMCID
PMC2376960
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]